News

Capricor Therapeutics Shares Insights at Major Conferences

Capricor Therapeutics Shares Insights at Major Conferences

Capricor Therapeutics to Showcase Innovations at Leading Conferences

SAN DIEGO - Capricor Therapeutics, a distinguished biotechnology firm dedicated to transformative therapies, is gearing up to present at several important investor and scientific conferences in the upcoming weeks. Specializing in cell and exosome-based therapeutics for rare diseases, Capricor's participation in these events will highlight its latest advancements.

Upcoming Conference Events

Capricor will take part in several significant conferences where it will share insights on its innovative advancements and future plans. Here are the details of the upcoming presentations:

H.C. Wainwright Annual Global Investment Conference

This conference is set for September 9, 2024, at 2:00 p.m. ET. It will include a company presentation and one-on-one meetings, allowing Capricor to connect with investors and stakeholders.

Annual Exosome-Based Therapeutic Summit

Scheduled for September 17 to 19, 2024, in Boston, this summit is vital for industry leaders. Capricor will participate with a company presentation and an industry panel focused on exosome therapies.

2024 Cantor Fitzgerald’s Global Healthcare Conference

Capricor will also present its progress at this conference on September 18, 2024, at 8:35 a.m. ET, which will feature a fireside chat and one-on-one meetings.

Key Updates on Deramiocel

At these conferences, Capricor's management will provide updates on deramiocel, the company’s flagship product candidate designed for treating Duchenne muscular dystrophy (DMD). Deramiocel (CAP-1002) is advancing through crucial phases of clinical development and has shown promising results in addressing this serious condition.

About Capricor Therapeutics

Capricor Therapeutics (NASDAQ: CAPR) is committed to advancing cell and exosome-based therapeutics that aim to transform the treatment landscape for rare diseases. Its lead candidate, deramiocel, is a cardiac-derived cell therapy that has demonstrated immunomodulatory, antifibrotic, and regenerative properties through extensive preclinical and clinical studies.

Currently, deramiocel is undergoing Phase 3 clinical trials for DMD, a severe genetic disorder marked by progressive muscle degeneration. The company is also leveraging its proprietary StealthX™ platform to explore exosome technology for targeted delivery of therapies across various diseases.

Capricor remains dedicated to innovating and advancing treatments for patients with unmet medical needs, advocating for their health and well-being. For more information about Capricor's innovative initiatives, please visit their official website at capricor.com.

Frequently Asked Questions

What is the focus of Capricor Therapeutics?

Capricor Therapeutics is focused on developing transformative therapies for rare diseases, particularly through cell and exosome-based therapeutics.

When is Capricor presenting at the H.C. Wainwright Annual Global Investment Conference?

The presentation is scheduled for September 9, 2024, at 2:00 p.m. ET.

What is deramiocel?

Deramiocel (CAP-1002) is Capricor's lead product candidate aimed at treating Duchenne muscular dystrophy, showing promise in clinical development.

Which technologies is Capricor developing?

Capricor is developing its proprietary StealthX™ platform, which utilizes exosome technology for targeted therapeutic delivery.

How can I learn more about Capricor's clinical trials?

To get detailed information about clinical trials and developments, visit Capricor's official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 69

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 129

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 40

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 267

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 172

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 288

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading

Top 5 Most Recently Viewed Articles

Hithium Showcases Innovative Energy Storage Solutions

Updated Category News Views 696

Hithium's Remarkable Presence at ESIE 2025 At the forefront of energy storage innovation, Hithium showcased its cutting-edge technologies at the 13th Energy Storage International Conference and Expo (ESIE 2025). This prominent event provided a platform for Hithium to demonstrate its full-spectrum energy storage solutions tailored to various applications, from...

Continue Reading
Work Truck Solutions Secures Strategic Investment for Growth

Updated Category News Views 423

Strategic Investment to Accelerate Growth Work Truck Solutions, a pioneering software provider for the commercial vehicle sector, has just announced a significant strategic majority investment from Rubicon Technology Partners, a private equity firm dedicated to advancing software companies. This partnership is set to empower Work Truck Solutions to further enhance its...

Continue Reading
Exploring Microsoft's Evolving Options Landscape: Key Insights

Updated Category News Views 126

Exploring Microsoft's Options Trading Landscape In recent weeks, Microsoft has seen a notable shift in options trading, with significant investors adopting a more cautious approach. It appears that these market players are now leaning bearish on Microsoft, reflecting broader market sentiments. Analyzing the history of options trades for Microsoft (MSFT) reveals a total of...

Continue Reading
AI Advances: McKinsey and AppliedAI Team Up

Updated Category News Views 32

A Game Changer in Regulated Industries? McKinsey & Company teaming up with AppliedAI is like throwing a fastball down the middle to regulated industries needing to modernize. For a world of compliance and paperwork, these heavy hitters are promising to slash process times like never before. The duo's latest venture aims to rewire enterprise operations from the ground up...

Continue Reading
Dollar Strengthens Against Yen Amid Mixed Economic Signals

Updated Category News Views 225

Dollar Strengthens Against Yen Amid Mixed Economic Signals The dollar is on track to conclude the week strongly, showcasing a near two-year high, largely influenced by a hawkish stance on U.S. interest rates. In contrast, the yen is facing significant challenges, struggling to maintain its stability and recently hitting a five-month low. Currency Market Movements After a...

Continue Reading